DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS
多巴胺能神经元选择性脆弱性的调节
基本信息
- 批准号:6302743
- 负责人:
- 金额:$ 12.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-01 至 2001-04-30
- 项目状态:已结题
- 来源:
- 关键词:6 hydroxydopamine Parkinson's disease SDS polyacrylamide gel electrophoresis centrifugation corpus striatum dopamine dopamine receptor experimental brain lesion immunocytochemistry laboratory rat neural degeneration neurons neurotoxins neurotransmitter metabolism oxidative stress pathologic process receptor binding receptor sensitivity substantia nigra
项目摘要
This project will focus on the role of reactive metabolites of
dopamine (DA) in the process of neurodegeneration. We
hypothesize that (a) the oxidation of DA to free radicals and
reactive DA quinones results in the selective destruction of DA
terminals, (b) this will occur with both exogenous and endogenous
DA, and ' the selectivity is due to the presence of high levels of
cytoplasmic DA within the terminal where oxidation occurs. We
have shown in rats that an intrastriatal injection of DA results in
the formation of DA oxidation products, proteins-bound cysteinyl-
catechols, and show evidence of selective toxicity to DA
terminals. In the proposed experiments, we will examine more
thoroughly the phenomenon of DA-induced toxicity in the rat
model using biochemical indices of DA oxidation and biochemical
and immunohistochemical indices of toxicity. First, we will
rigorously examine whether exogenous DA produces a selective
loss DA terminals, and whether the loss of terminals results in the
subsequent loss of DA cells in the substantia nigra. Secondly, we
will examine the vulnerability of DA terminals to DA-induced
toxicity under conditions more readily associated with the disease
such as in the aged, antioxidant-deficient, or metabolically-
impaired rat. In addition, we will examine the neurotoxic effects
of chronically administered intrastriatal DA and induces of DA
oxidation following increased availability of endogenous DA in the
6-OHDA-lesioned rat exposed to L-dOPA. Thirdly, we will
examine the role of DA uptake and DA metabolism as the
mechanism associated with the selective vulnerability of DA
terminals to DA-induced oxidative stress. This group of studies
will examine the role of DA as opposed to other oxidants, and the
effect of blocking DA uptake or DA metabolism on the selective
toxicity to DA terminals. Finally, we will begin to examine
potential protein targets of DA quinone binding both intracellularly
and extracellularly. Specific effects of extracellular reactive
metabolites on DA receptor binding will be examined as part of
this study. The results of these studies will help to clarify
whether reactive metabolites of DA may be contributing to the
pathogenesis associated with the loss of DA neurons in
Parkinson's disease as well as identify potentially useful
therapeutic interventions.
本项目将重点研究活性代谢物的作用。
多巴胺(DA)在神经退变过程中的作用我们
假设(A)DA氧化为自由基和
反应性DA对苯二酚的选择性破坏作用
终端,(B)这将发生在外源和内源的情况下
DA,以及‘选择性是由于存在高水平的
在发生氧化的末端,胞质中有DA。我们
已经在大鼠身上表明纹状体内注射DA会导致
DA氧化产物的形成,蛋白质结合的半胱氨酸基-
儿茶酚,并显示对DA有选择性毒性的证据
终点站。在拟议的实验中,我们将检查更多
大鼠多巴胺中毒现象的研究进展
DA氧化生化指标与生化指标的关系模型
和免疫组织化学毒性指标。首先,我们将
严格检查外源性DA是否会产生选择性
丢失DA终端,以及终端丢失是否会导致
随后黑质中DA细胞的丢失。其次,我们
将检查DA终端对DA诱导的脆弱性
在更容易与疾病相关的条件下的毒性
例如老年人,抗氧化剂缺乏,或新陈代谢-
受损的老鼠。此外,我们还将检查神经毒性效应。
纹状体内长期给药的多巴胺及其诱因
内源DA利用率增加后的氧化作用
6-羟基多巴胺损毁大鼠暴露于L-多巴。第三,我们将
研究DA摄取和DA代谢的作用
与DA的选择性脆弱性相关的机制
DA诱导的氧化应激的终末。这组研究
将研究DA相对于其他氧化剂的作用,以及
阻断多巴胺摄取或代谢对选择性脑损伤的影响
对多巴胺终末的毒性。最后,我们将开始检查
DA苯醌与细胞内结合的潜在蛋白质靶点
以及细胞外。胞外反应的特殊作用
关于DA受体结合的代谢物将作为
这项研究。这些研究的结果将有助于澄清
多巴胺的反应性代谢物是否可能对
大鼠脑内DA能神经元缺失的发病机制
帕金森氏症以及识别潜在有用的
治疗性干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERESA G HASTINGS其他文献
TERESA G HASTINGS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERESA G HASTINGS', 18)}}的其他基金
Dopamine Toxicity and Mitochondrial Dysfunction
多巴胺毒性和线粒体功能障碍
- 批准号:
7072235 - 财政年份:2002
- 资助金额:
$ 12.18万 - 项目类别:
Dopamine Toxicity and Mitochondrial Dysfunction
多巴胺毒性和线粒体功能障碍
- 批准号:
6629465 - 财政年份:2002
- 资助金额:
$ 12.18万 - 项目类别:
Dopamine Toxicity and Mitochondrial Dysfunction
多巴胺毒性和线粒体功能障碍
- 批准号:
6508297 - 财政年份:2002
- 资助金额:
$ 12.18万 - 项目类别:
Dopamine Toxicity and Mitochondrial Dysfunction
多巴胺毒性和线粒体功能障碍
- 批准号:
6894807 - 财政年份:2002
- 资助金额:
$ 12.18万 - 项目类别:
Dopamine Toxicity and Mitochondrial Dysfunction
多巴胺毒性和线粒体功能障碍
- 批准号:
6765785 - 财政年份:2002
- 资助金额:
$ 12.18万 - 项目类别:
Control of neuronal ROS generation by membrane potential
通过膜电位控制神经元ROS的产生
- 批准号:
6796688 - 财政年份:2001
- 资助金额:
$ 12.18万 - 项目类别:
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS
多巴胺能神经元选择性脆弱性的调节
- 批准号:
6610370 - 财政年份:2001
- 资助金额:
$ 12.18万 - 项目类别:
Control of neuronal ROS generation by membrane potential
通过膜电位控制神经元ROS的产生
- 批准号:
6944710 - 财政年份:2001
- 资助金额:
$ 12.18万 - 项目类别:
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS
多巴胺能神经元选择性脆弱性的调节
- 批准号:
6448231 - 财政年份:2001
- 资助金额:
$ 12.18万 - 项目类别:
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS
多巴胺能神经元选择性脆弱性的调节
- 批准号:
6323408 - 财政年份:2000
- 资助金额:
$ 12.18万 - 项目类别:
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 12.18万 - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 12.18万 - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
$ 12.18万 - 项目类别:
Studentship
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Operating Grants
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
- 批准号:
22KJ2095 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
- 批准号:
2881438 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Studentship
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
- 批准号:
MR/X005267/1 - 财政年份:2023
- 资助金额:
$ 12.18万 - 项目类别:
Research Grant